
|Articles|May 1, 2002
Supplements and Featured Publications
- Cost and Utilization Analysis for Rheumatoid Arthritis Treatments: An Update for Managed Care
- Volume 8
- Issue 7 Suppl
Impact of Leflunomide Versus Biologic Agents on the Costs of Care for Rheumatoid Arthritis in a Managed Care Population
Advertisement
Articles in this issue
about 24 years ago
Participating FacultyAdvertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
Walcker Named President of Cardinal’s The Specialty Alliance, With Strengths in GI, Urology
2
Ontada Analysis Finds GLP-1 RA Use Linked to Improved Survival in Patients With Cancer
3
Oral COVID-19 PEP May Benefit High-Risk Groups More Than General Public: Peter J. Hotez, MD
4
Orexin Agonist Shows Promise for Treating Narcolepsy, Hypersomnia: Richard Bogan, MD
5





